Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral antimicrobial treatment vs. outpatient parenteral for infective endocarditis
2024-519969-21-00Phase 4Authorised
- Sponsor
- IDIBAPS
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of amoxicillin in endocarditis (IE) (2 arms), sponsored by IDIBAPS. Primary endpoint: Composite endpoint of clinical outcomes at 6 months. Planned start Jan 2025; status: authorised.
02
Drugs
amoxicillin
03
Conditions
endocarditis (IE)
Beyond the preview
Go deeper on 2024-519969-21-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-519969-21-00.